Trends in antimicrobial resistance of Shigella species in Peru, 2011-2020

Willi Quino1, Gustavo Bellido1, Diana Flores-León1,2

  • 1Laboratorio de Referencia Nacional de Bacteriología Clínica, Instituto Nacional de Salud, Lima, Perú.

PubMed
Abstract

Insights

Antimicrobial resistance in Shigella species in Peru is high, particularly for trimethoprim/sulfamethoxazole and tetracycline. Resistance to fluoroquinolones like ciprofloxacin is increasing, posing a threat to treating Shigella infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Shigella species are a major cause of bacterial dysentery worldwide.
  • Antimicrobial resistance in Shigella poses a significant public health threat, complicating treatment and increasing morbidity and mortality.
  • Understanding the trends of antimicrobial resistance is crucial for effective treatment strategies and disease control.

Purpose of the Study:

  • To determine the frequency of antimicrobial resistance rates in Shigella species.
  • To analyze the spatial-temporal distribution of Shigella species over a 10-year period in Peru.
  • To identify trends in antimicrobial resistance patterns for effective public health interventions.

Main Methods:

  • A cross-sectional descriptive study analyzed 1668 Shigella strains from 2011-2020.
  • Strains were confirmed using conventional tests and serotyped.
  • Antimicrobial susceptibility testing was performed using the Kirby-Bauer method.

Main Results:

  • Shigella sonnei (49.2%) was the most frequent species, followed by S. flexneri (42.2%).
  • High resistance rates were observed for trimethoprim/sulfamethoxazole (91.0%), tetracycline (88.4%), and ampicillin (73.9%).
  • A significant increase in antimicrobial resistance to fluoroquinolones, including ciprofloxacin, was noted from 2017 to 2020.

Conclusions:

  • Shigella sonnei is the predominant species, exhibiting high resistance to trimethoprim/sulfamethoxazole.
  • The growing resistance to fluoroquinolones and other commonly used antibiotics is alarming.
  • Urgent interventions are needed to combat rising antimicrobial resistance and manage Shigella infections effectively.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
17
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
24
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
130